Celldex Therapeutics Ownership | Who Owns Celldex Therapeutics?
Celldex Therapeutics Ownership Summary
Celldex Therapeutics is owned by 128.62% institutional investors, 0.27% insiders. Wellington management group llp is the largest institutional shareholder, holding 14.34% of CLDX shares. Vanguard Health Care Inv is the top mutual fund, with 5.45% of its assets in Celldex Therapeutics shares.
CLDX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Celldex Therapeutics | 128.62% | 0.27% | -28.89% |
| Sector | Healthcare Stocks | 50.59% | 12.40% | 37.01% |
| Industry | Biotech Stocks | 49.10% | 12.14% | 38.76% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Wellington management group llp | 9.54M | 14.34% | $355.12M |
| Blackrock funding, inc. /de | 7.00M | 10.52% | $260.56M |
| Kynam capital management, lp | 5.32M | 8.00% | $198.07M |
| Blackrock | 4.69M | 7.97% | $173.61M |
| Price t rowe associates inc /md/ | 4.69M | 7.04% | $174.34M |
| Vanguard group | 4.03M | 6.06% | $109.38M |
| State street | 3.90M | 5.86% | $145.13M |
| Fmr | 3.72M | 5.59% | $138.53M |
| Vanguard capital management | 3.46M | 5.21% | $128.93M |
| Deep track capital, lp | 2.94M | 4.42% | $109.37M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Kynam capital management, lp | 5.32M | 10.95% | $198.07M |
| Superstring capital management lp | 287.58K | 6.76% | $10.70M |
| 5am venture management | 497.27K | 6.43% | $18.50M |
| Foresite capital management vi | 879.71K | 5.09% | $32.73M |
| Eversept partners, lp | 1.79M | 3.45% | $66.45M |
| Logos global management lp | 2.10M | 3.36% | $78.14M |
| Tsp capital management group | 371.13K | 3.30% | $13.81M |
| Commodore capital lp | 1.35M | 2.99% | $50.23M |
| Rosalind advisors | 200.00K | 2.76% | $7.44M |
| Novo | 1.02M | 2.21% | $38.14M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Price t rowe associates inc /md/ | 4.69M | 0.02% | 2.60M |
| Deep track capital, lp | 2.94M | 1.59% | 1.66M |
| Logos global management lp | 2.10M | 3.36% | 1.65M |
| Blackrock funding, inc. /de | 7.00M | 0.00% | 1.63M |
| State street | 3.90M | 0.00% | 1.10M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Point72 asset management | 117.22K | 0.00% | -3.11M |
| T. rowe price investment management | - | - | -1.70M |
| Commodore capital lp | 1.35M | 2.99% | -1.35M |
| Jennison associates | - | - | -1.32M |
| Vestal point capital, lp | - | - | -1.22M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Driehaus capital management | 989.44K | 0.21% | 989.44K | $36.82M |
| Sixth street partners management company | 655.95K | 0.00% | 655.95K | $24.41M |
| Federated hermes | 492.89K | 0.03% | 492.89K | $18.34M |
| Trexquant investment lp | 184.52K | 0.04% | 184.52K | $6.87M |
| Axa investment managers | 121.33K | 0.01% | 121.33K | $3.14M |
Sold Out
| Holder | Change |
|---|---|
| Umb bank, n.a. | -2.00 |
| Strategic investment solutions, inc. /il | -5.00 |
| Scarborough advisors | -6.00 |
| Mai capital management | -8.00 |
| Nelson, van denburg & campbell wealth management group | -10.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 268 | 14.53% | 85,613,858 | 17.37% | 128 | 1.07% | 158 | 24.41% | 57 | -1.72% |
| Mar 31, 2026 | 230 | 22.99% | 72,850,785 | -0.75% | 109 | 0.90% | 124 | 49.40% | 58 | -3.33% |
| Dec 31, 2025 | 112 | -41.05% | 27,037,989 | -61.77% | 40 | 0.36% | 48 | -51.02% | 35 | -31.37% |
| Sep 30, 2025 | 180 | 2.27% | 69,405,041 | -0.96% | 104 | 0.94% | 95 | -14.41% | 50 | 31.58% |
| Jun 30, 2025 | 184 | 3.95% | 72,686,228 | 0.53% | 109 | 0.92% | 113 | 25.56% | 41 | -22.64% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Health Care Inv | 4.28M | 5.45% | - |
| BB Biotech AG Ord | 3.56M | 5.34% | 250.10K |
| Vanguard MStar Total Stk Mkt Idx Invest | 2.50M | 3.19% | 13.41K |
| Vanguard Total Stock Mkt Idx Inv | 2.49M | 3.17% | 30.39K |
| Vanguard Morn Total Stk Mkt Idx Investor | 2.49M | 3.17% | 30.39K |
| Vanguard US Total Market Shares ETF | 2.07M | 3.11% | 2.12K |
| iShares Russell 2000 ETF | 1.99M | 2.54% | -35.42K |
| State Street® SPDR® S&P® Biotech ETF | 1.99M | 2.53% | 4.57K |
| Vanguard Explorer Inv | 1.45M | 1.84% | 390.07K |
| Polar Capital Healthcare Opports Inc | 1.15M | 1.73% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Dec 04, 2025 | Jimenez Freddy A. | SVP & GENERAL COUNSEL | Sell | $121.21K |
| Nov 13, 2025 | Wright Richard M. | Former Officer | Sell | $1.18M |
| Aug 13, 2025 | Jimenez Freddy A. | SVP & GENERAL COUNSEL | Sell | $8.17K |
| Aug 13, 2025 | Jimenez Freddy A. | SVP & GENERAL COUNSEL | Sell | $10.93K |
| Nov 11, 2024 | Marucci Anthony S | PRESIDENT & CEO | Buy | $308.43K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | - | 2 |
| 2025 Q3 | - | 2 |
| 2025 Q2 | - | - |
| 2024 Q4 | 1 | - |
| 2024 Q2 | - | 12 |
CLDX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools